Bank of America
OMGA

Bank of America’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Bank of America’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,094
Closed -$3.79K – 8680
2024
Q4 		$3.79K Sell
5,094
-11,503
-69% -$11.5K ﹤0.01% 7128
2024
Q3 		$20.2K Buy
16,597
+6,137
+59% +$9.77K ﹤0.01% 6737
2024
Q2 		$21.7K Sell
10,460
-11,196
-52% -$26.4K ﹤0.01% 6723
2024
Q1 		$79K Sell
21,656
-37,297
-63% -$143K ﹤0.01% 6356
2023
Q4 		$177K Buy
58,953
+41,549
+239% +$84.2K ﹤0.01% 6126
2023
Q3 		$37.4K Buy
17,404
+4,137
+31% +$16.5K ﹤0.01% 6578
2023
Q2 		$74.3K Sell
13,267
-17,895
-57% -$140K ﹤0.01% 6319
2023
Q1 		$188K Buy
31,162
+21,814
+233% +$152K ﹤0.01% 5951
2022
Q4 		$53.4K Buy
9,348
+909
+11% +$5.1K ﹤0.01% 6456
2022
Q3 		$46K Buy
8,439
+4,683
+125% +$23.7K ﹤0.01% 6714
2022
Q2 		$14K Sell
3,756
-12,452
-77% -$46.4K ﹤0.01% 7303
2022
Q1 		$101K Buy
16,208
+6,787
+72% +$69.3K ﹤0.01% 6858
2021
Q4 		$107K Buy
9,421
+9,098
+2,817% +$173K ﹤0.01% 6855
2021
Q3 		$6K Buy
+323
New +$6.2K ﹤0.01% 7705

Other funds holding OMGA

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $8.31B AUM 21.94% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Bank of America's OMGA Position: Q1 2025 in Review

Bank of America sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2025, closing a stake of 5,094 shares — an estimated $3.79K sold.

Bank of America first reported a position in OMGA in Q3 2021 and held it in 14 quarters. The position peaked at $188K in Q1 2023. 4 funds tracked by Wall St. Rank hold OMGA as of Q1 2025.

  • Bank of America reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Bank of America sold 5,094 Omega Therapeutics, Inc. Common Stock shares in Q1 2025, an estimated $3.79K.
  • Bank of America first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 14 quarters.
  • Bank of America's Omega Therapeutics, Inc. Common Stock position peaked at $188K in Q1 2023.
  • 4 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2025.

Based on Bank of America's 13F filing for Q1 2025, filed 15 May 2025.